23 Results

People

  1. Scheinberg
    Scheinberg
  2. Begg
    Begg
  3. Busam
    Busam
  4. Hummer
    Hummer
  5. Jurcic
    Jurcic
  6. Maslak
    Maslak
  7. Mcdevitt
    Mcdevitt
  8. Mujumdar
    Mujumdar
  9. Pinilla
    Pinilla
  10. Dao
    Dao

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  2. Molecular Pharmacology and Chemistry Program Faculty (23)
  3. Sloan Kettering Institute Faculty (23)
  4. Department of Medicine (16)
  5. GSK Faculty (15)
  6. Adult Leukemia (13)
  7. Center for Hematologic Malignancies (13)
  8. Hematologic Malignancies Research (13)
  9. Hematologic Malignancies, Division of (13)
  10. Tow Center for Developmental Oncology (TCDO) (13)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
  2. "2006"
  3. "Sloan Kettering Institute Faculty"
  4. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
Formats
  1. Journal Article (15)
  2. Meeting Abstract (8)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  2. Molecular Pharmacology and Chemistry Program Faculty (23)
  3. Sloan Kettering Institute Faculty (23)
  4. Department of Medicine (16)
  5. GSK Faculty (15)
  6. Adult Leukemia (13)

More Groups

People
  1. David Scheinberg (13)
  2. Colin Begg (9)
  3. Klaus Busam (5)
  4. Amanda Hummer (4)
  5. Javier Pinilla (4)
  6. Joseph Jurcic (4)

More People

Years
  1. 2006 (23)
Publications
  1. Blood (3)
  2. Cancer Biotherapy and Radiopharmaceuticals (2)
  3. Journal of Clinical Oncology (2)
  4. American Journal of Epidemiology (1)
  5. Applied Radiation and Isotopes (1)
  6. Bioconjugate Chemistry (1)

More Publications

Publishers
  1. Oxford University Press (4)
  2. American Society of Hematology (3)
  3. American Association for Cancer Research (2)
  4. American Society of Clinical Oncology (2)
  5. Mary Ann Liebert, Inc (2)
  6. Nature Publishing Group (2)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Melanomas arising in nevus-prone individuals are more likely to harbor a BRAF/NRAS mutation
    Meeting Abstract

    Thomas, N. E.; Alexander, A.; Edmiston, S. N.; Millikan, R. C.; Groben, P.; Hao, H.; Tolbert, D.; Berwick, M.; Busam, K.; Begg, C.; more...
    Journal of Investigative Dermatology (2006)

    Fulltext@MSK | Save
  • Relative biological effectiveness for efficacy and toxicity in leukemia patients of the alpha-particle emitter, bismuth-213
    Meeting Abstract

    Sgouros, G.; Bolch, W. E.; Shah, A.; Watchman, C. J.; Jurcic, J. G.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • CD4+peptide epitopes from the WT1 oncoprotein stimulate CD4+and CD8+T cells that recognize and kill leukemia and solid tumor cells
    Meeting Abstract

    May, R. J.; Pinilla, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Dao, T.; Maslak, P.; Scheinberg, D. A.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • A pilot phase II trial of a synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal residual disease
    Meeting Abstract

    Cortes, J.; Reuben, J. M.; Scheinberg, D.; Lee, B. N.; Gao, H.; Li, C.; Mazanet, R.; Jones, D.; Kantarjian, H.
    Blood (2006)

    Fulltext@MSK | Save
  • SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • The interaction of radiation, the ATM gene and breast cancer
    Meeting Abstract

    Bernstein, J.; Bernstein, L.; Langholz, B.; Thomas, D.; Stovall, M.; Capanu, M.; Thompson, W. D.; Olson, J.; Malone, K.; Lynch, C.; more...
    American Journal of Epidemiology (2006)

    Fulltext@MSK | Save
  • Marketing drugs too early in testing
    Journal Article

    Begg, C. B.; Brawley, O.; Califf, R. M.; Demets, D. L.; Ellenberg, S. S.; Kaplan, R. S.
    Science (2006)

    Fulltext@MSK | Save
  • Cancer survivorship - Genetic susceptibility and second primary cancers: Research strategies and recommendations
    Journal Article

    Travis, L. B.; Rabkin, C. S.; Brown, L. M.; Allan, J. M.; Alter, B. P.; Ambrosone, C. B.; Begg, C. B.; Caporaso, N.; Chanock, S.; DeMichele, A.; more...
    JNCI: Journal of the National Cancer Institute (2006)

    Fulltext@MSK | Save